NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-171-2018-8-US-05 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/900,363 Abandoned
NCATS E-229-2020-0-CO-01 Methods Of Combination Therapy For Treatment Of Mucopolysaccharidosis Type IVA Using Human Recombinant Nacetylgalactosamine
6-sulfatase (hrGALNS) And Pharmacological Chaperones 		CO ORD NC2020/0007242 Pending
NCI E-021-2015-0-AU-32 Anti-CD70 Chimeric Antigen Receptors AU DIV 2020203836 Issued
NIBIB E-005-2012-3-US-12 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US DIV 16/897,525 Pending
NCI E-085-2013-0-US-25 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD US DIV 16/893,972 11679128 Issued PDF
NICHD E-039-2016-1-AU-07 Treatment of Hormonal Disorders of Growth AU DIV 2020203709 Issued
NCI E-167-2017-0-KR-08 NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY KR National Stage 10-2020-7016052 Pending
NIDCR E-485-2013-1-EP-03 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS EP National Stage 18804851.6 Issued
NIDCR E-485-2013-1-GB-07 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS GB EP 18804851.6 Issued
NIDCR E-485-2013-1-DE-05 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS DE EP 18804851.6 Issued
NIDCR E-485-2013-1-FR-06 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS FR EP 18804851.6 Issued
NCI E-239-2017-0-JP-12 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS JP National Stage 2020-530325 Issued
NCI E-239-2017-0-US-17 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US National Stage 16/769,144 11466071 Issued PDF
NCI E-238-2017-0-US-03 METHODS OF ENRICHING CELL POPULATIONS FOR CANCER-SPECIFIC T CELLS USING IN VITRO STIMULATION OF MEMORY T CELLS US National Stage 16/768,930 Pending
NCI E-174-2018-2-US-13 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US DIV 16/889,914 Abandoned
NINR E-223-2018-1-US-02 Rapid Nucleic Acids Preparation/Sample Preparation Via Hollow Centere Silica Microsphere US National Stage 16/768,802 Pending
NCI E-174-2018-2-US-11 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US CON 16/885,874 11154574 Issued PDF
NCI E-174-2018-2-US-12 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US CON 16/885,882 Abandoned
NHLBI E-249-2006-3-US-10 Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection US CON 16/882,896 11925558 Issued PDF
NEI E-050-2015-0-DE-16 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa DE EP 20176667.2 Issued
NEI E-050-2015-0-FR-14 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa FR EP 20176667.2 Issued
NEI E-050-2015-0-IT-15 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa IT EP 20176667.2 Issued
NEI E-050-2015-0-GB-17 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa GB EP 20176667.2 Issued
NEI E-050-2015-0-EP-13 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa EP DIV 20176667.2 Issued
NCI E-028-2015-1-AU-36 ANTI-MUTATED KRAS T CELL RECEPTORS AU DIV 2020203465 Issued
NIAID E-080-2013-0-AU-08 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization AU DIV 2020203460 Issued
NICHD E-003-2018-1-US-02 AUTOPHAGY MODULATORS FOR USE IN TREATING CANCER US National Stage 16/883,046 11471460 Issued PDF
NCI E-495-2013-0-HK-20 Anti-Human Papillomavirus 16 E6 T Cell Receptors HK EP 42020008016.6 Pending
NIAID E-076-2019-0-PCT-02 MAMMALIAN CELL FOR PRODUCING MODIFIED VACCINIA ANKARA (MVA) VIRUS PCT PCT PCT/US20/33788 Expired
NIAMS E-024-2018-0-US-06 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING AND/OR PREVENTING PERIODONTAL DISEASE US National Stage 16/765,420 Pending
NCI E-042-2014-0-NZ-18 Chimeric Antigen Receptors Targeting CD-19 NZ DIV 764530 Pending
NCATS E-026-2016-0-US-19 Compounds for Improving mRNA Splicing US CON 16/877,254 11702417 Issued PDF
NIAID E-241-2014-0-US-08 RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 1 (HPIV1) EXPRESSING A CHIMERIC RSV/HPIV1 F PROTEIN AND USES THEREOF US CON 16/877,319 11591372 Issued PDF
NIAID E-216-2014-0-US-15 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES US CON 16/877,277 11332721 Issued PDF
NCI E-094-2017-0-JP-08 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment JP DIV 2020-085861 Issued
NCI E-085-2013-0-CN-26 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood CN DIV 202010410564.8 Issued
NHLBI E-186-2014-1-US-15 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 US CON 15/930,057 11384131 Issued PDF
CC E-028-2017-0-US-03 DEVICES WITH LOW MELTING POINT ALLOY FOR CONTROL OF DEVICE FLEXIBILITY US DIV 16/872,519 Pending
NIMH E-174-2006-0-US-16 Intranasal Administration Of Ketamine To Treat Depression US CON 15/930,140 Pending
NIDA E-005-2018-1-US-02 ATYPICAL INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US National Stage 16/762,998 11365195 Issued PDF
NCI E-495-2013-0-HK-21 Anti-Human Papillomavirus 16 E6 T Cell Receptors HK CN 42020007152.0 Issued
NCI E-291-2012-0-US-24 M971 CHIMERIC ANTIGEN RECEPTORS US DIV 16/869,792 11807682 Issued PDF
NIAAA E-282-2012-0-US-11 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US DIV 16/870,093 11485709 Issued PDF
NCI E-016-2018-0-US-06 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 OR MESOTHELIN US National Stage 16/762,459 11802163 Issued PDF
NCI E-132-2017-0-US-03 METHODS OF PREPARING HEMATOPOIETIC PROGENITOR CELLS IN VITRO US National Stage 16/762,447 Pending
NCI E-167-2017-0-EP-06 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY EP National Stage 18819232.2 Pending
NCI E-064-2019-0-EP-01 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 EP National Stage 20802725.0 Pending
NCI E-064-2019-0-CA-03 Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development CA National Stage 3139507 Pending
NCI E-064-2019-0-PCT-02 Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development PCT PCT PCT/US2020/031729 Expired
NCI E-182-2017-0-IT-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION IT EP 18786145.5 Issued